Lanreotide Depot to Treat Gastroenteropancreatic Neuroendocrine Tumors in a US Community Oncology Setting: A Prospective, Observational Study

INTRODUCTION: Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) can result in symptoms such as diarrhea, flushing, abdominal pain, and fatigue and are often associated with a significant disease burden and poor prognosis. This non-interventional, prospective, observational study evaluated the...

Descripción completa

Detalles Bibliográficos
Autores principales: Paulson, Scott, Ray, David, Aranha, Sharan, Scales, Amy, Wang, Yunfei, Liu, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681944/
https://www.ncbi.nlm.nih.gov/pubmed/36136274
http://dx.doi.org/10.1007/s40487-022-00208-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681944/
https://www.ncbi.nlm.nih.gov/pubmed/36136274
http://dx.doi.org/10.1007/s40487-022-00208-1

Ejemplares similares